Select a relevant service

Evaluate data collected during drug development to maximize the value of a therapeutic product.

Communicate scientific, technical and health-related information to a range of audiences.

Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.

Identify, measure and compare the cost-benefit ratio of products and services.

Compare alternative treatments that lead to similar health outcomes.

Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.

Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.

Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.

Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder (manufacturer, payer, provider, HTA agency, etc.). See also HTA Submission.

The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.